Bacterial nanocellulose patches as a carrier for hydrating formulations to improve the topical treatment of nail diseases.
Bacterial nanocellulose
Drug Delivery
Nail Psoriasis
Nails
Onychomycosis
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Nov 2022
25 Nov 2022
Historique:
received:
01
07
2022
revised:
30
09
2022
accepted:
01
10
2022
pubmed:
10
10
2022
medline:
16
11
2022
entrez:
9
10
2022
Statut:
ppublish
Résumé
Bacterial nanocellulose has been widely investigated for wound healing applications, mainly due to its moisturizing capabilities and biocompatibility. Even though the topical therapy of nail diseases could benefit from these properties, this application has not yet been investigated. Therefore, actively hydrating nail patches based on bacterial nanocellulose were developed to improve the delivery of ciclopirox olamine and Boswellia serrata extract through the nail plate. The nanocellulose matrix was used to enable the application of hydration enhancing solutions based on glycerol and urea as a mechanically stable patch. While the favorable mechanical characteristics of the material remained unchanged, an increase of the incorporated glycerol concentration enhanced the transparency and wetting capacity of the patches. A biphasic drug release from the patches could be observed for drug and extract with a faster release for the hydrophilic ciclopirox olamine. High glycerol concentrations correlated with increased cumulative release and permeation through keratin films for drug and extract, demonstrating the hydration driven permeation enhancement. Patches containing ciclopirox olamine showed strong antimycotic effects against relevant pathogens for onychomycosis. The present finding proposed the combination of bacterial nanocellulose with glycerol, urea and different drug as a promising platform for the local treatment of nail diseases.
Identifiants
pubmed: 36209980
pii: S0378-5173(22)00822-5
doi: 10.1016/j.ijpharm.2022.122267
pii:
doi:
Substances chimiques
Ciclopirox
19W019ZDRJ
Antifungal Agents
0
Glycerol
PDC6A3C0OX
Pyridones
0
Excipients
0
Urea
8W8T17847W
Plant Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122267Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.